Notification of Interim Results (6772M)

TIDMATD

RNS Number : 6772M

Asterand PLC

19 August 2011

 
 For Immediate Release   19 August 2011

ASTERAND PLC

('Asterand' or 'the Company')

Notification of Interim Results

Date: Wednesday 31 August 2011

Asterand plc ("Asterand" or the "Group" - LSE: ATD), a leading supplier of human tissue based solutions to pharmaceutical and biotechnology companies engaged in drug discovery research will announce its Interim Results for the period ended 30 June 2011, on Wednesday 31 August 2011.

- Ends -

Contacts:

 
 Asterand plc 
 Jack Davis, Chairman and Interim Chief   Tel: + 44 (0) 1763 211 600 / + 
  Executive Officer                        1 (313) 263-0960 
 John Stchur, Chief Financial Officer     As above 
 
 Buchanan Communications 
 Lisa Baderoon / Mark Court / Isabel      Tel: +44 (0) 20 7466 5000 
  Podda 
 
 Daniel Stewart & Company plc 
 Antony Legge                             Tel: +44 (0) 20 7776 6550 
 Martin Lampshire

About Asterand

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORSFWSWUFFSESA

Bioseek (LSE:ATD)
Historical Stock Chart
From Jun 2024 to Jul 2024